Literature DB >> 17117407

Novel mutations in the small leucine-rich repeat protein/proteoglycan (SLRP) genes in high myopia.

Marja Majava1, Paul N Bishop, Pasi Hägg, Paul G Scott, Aine Rice, Chris Inglehearn, Christopher J Hammond, Tim D Spector, Leena Ala-Kokko, Minna Männikkö.   

Abstract

The importance of the genetic component in high myopia has been well established in population and family studies, but only a few candidate genes have been explored to date. The extracellular matrix small leucine-rich repeat proteins/proteoglycans (SLRPs) regulate collagen fibril diameter and spacing. Given their role in extracellular matrix assembly and expression in the eye, they are likely to regulate its shape and size. Analysis of 85 English and 40 Finnish subjects with high myopia (refractive error of -6 diopters [D] or greater) resulted in 23 sequence variations in four SLRP genes, LUM, FMOD, PRELP, and OPTC. We observed higher number of variations in OPTC in English patients than in controls (p=0.042), and a possibly protective variation in LUM (c.893-105G>A) with p-value of 0.0043. Two intronic variations, six nonsynonymous and one synonymous amino acid changes, were not found in any of the nonmyopic controls. Five changes were detected in opticin, Thr177Arg, Arg229His, Arg325Trp, Gly329Ser, and Arg330His, and all but one (Arg229His) were shown to cosegregate with high myopia in families with incomplete penetrance. A homology model for opticin revealed that Arg229His and Arg325Trp are likely to disrupt the protein structure, and PolyPhen analysis suggested that Thr177Arg, Arg325Trp, and Gly329Ser changes may be damaging. A Leu199Pro change in lumican and Gly147Asp and Arg324Thr variations in fibromodulin are located in the highly conserved leucine-rich repeat (LRR) domains. This study provides new insight into the genetics of high myopia, suggesting that sequence variations in the SLRP genes expressed in the eye may be among the genetic risk factors underlying the pathogenesis of high myopia. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17117407     DOI: 10.1002/humu.20444

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  24 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 2.  Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.

Authors:  Liliana Schaefer; Renato V Iozzo
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

Review 3.  Regulation of corneal stroma extracellular matrix assembly.

Authors:  Shoujun Chen; Michael J Mienaltowski; David E Birk
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

4.  The integrin needle in the stromal haystack: emerging role in corneal physiology and pathology.

Authors:  Sunil K Parapuram; William Hodge
Journal:  J Cell Commun Signal       Date:  2014-03-07       Impact factor: 5.782

5.  The association of lumican polymorphisms and high myopia in a Southern Chinese population.

Authors:  Gui-Fang Wang; Qing-Shan Ji; Bing Qi; Guo-Cheng Yu; Lian Liu; Jing-Xiang Zhong
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

Review 6.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

7.  Construction of adenovirus vectors encoding the lumican gene by gateway recombinant cloning technology.

Authors:  Gui-Fang Wang; Bing Qi; Lei-Lei Tu; Lian Liu; Guo-Cheng Yu; Jing-Xiang Zhong
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

8.  Development of myotendinous-like junctions that anchor cardiac valves requires fibromodulin and lumican.

Authors:  Loren E Dupuis; Lorna Doucette; A Kittrell Rice; Ashton E Lancaster; Matthew G Berger; Shukti Chakravarti; Christine B Kern
Journal:  Dev Dyn       Date:  2016-08-25       Impact factor: 3.780

9.  An evaluation of OPTC and EPYC as candidate genes for high myopia.

Authors:  Panfeng Wang; Shiqiang Li; Xueshan Xiao; Xiangming Guo; Qingjiong Zhang
Journal:  Mol Vis       Date:  2009-10-15       Impact factor: 2.367

10.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.